Literature DB >> 11514724

Complete nucleotide sequences of Nipah virus isolates from Malaysia.

Y P Chan1, K B Chua1, C L Koh1, M E Lim1, S K Lam1.   

Abstract

We have completely sequenced the genomes of two Nipah virus (NiV) isolates, one from the throat secretion and the other from the cerebrospinal fluid (CSF) of the sole surviving encephalitic patient with positive CSF virus isolation in Malaysia. The two genomes have 18246 nucleotides each and differ by only 4 nucleotides. The NiV genome is 12 nucleotides longer than the Hendra virus (HeV) genome and both genomes have identical leader and trailer sequence lengths and hexamer-phasing positions for all their genes. Both NiV and HeV are also very closely related with respect to their genomic end sequences, gene start and stop signals, P gene-editing signals and deduced amino acid sequences of nucleocapsid protein, phosphoprotein, matrix protein, fusion protein, glycoprotein and RNA polymerase. The existing evidence demonstrates a clear need for the creation of a new genus within the subfamily Paramyxovirinae to accommodate the close similarities between NiV and HeV and their significant differences from other members of the subfamily.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514724     DOI: 10.1099/0022-1317-82-9-2151

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  33 in total

Review 1.  How order and disorder within paramyxoviral nucleoproteins and phosphoproteins orchestrate the molecular interplay of transcription and replication.

Authors:  Sonia Longhi; Louis-Marie Bloyet; Stefano Gianni; Denis Gerlier
Journal:  Cell Mol Life Sci       Date:  2017-06-09       Impact factor: 9.261

Review 2.  Hendra and nipah infection: pathology, models and potential therapies.

Authors:  Frederic Vigant; Benhur Lee
Journal:  Infect Disord Drug Targets       Date:  2011-06

3.  Establishment of a Nipah virus rescue system.

Authors:  Misako Yoneda; Vanessa Guillaume; Fusako Ikeda; Yuki Sakuma; Hiroki Sato; T Fabian Wild; Chieko Kai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

4.  Hendra virus and Nipah virus animal vaccines.

Authors:  Christopher C Broder; Dawn L Weir; Peter A Reid
Journal:  Vaccine       Date:  2016-05-04       Impact factor: 3.641

5.  Nipah virus uses leukocytes for efficient dissemination within a host.

Authors:  Cyrille Mathieu; Christine Pohl; Judit Szecsi; Selena Trajkovic-Bodennec; Séverine Devergnas; Hervé Raoul; François-Loïc Cosset; Denis Gerlier; T Fabian Wild; Branka Horvat
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

6.  Nipah virus edits its P gene at high frequency to express the V and W proteins.

Authors:  Sachin Kulkarni; Valentina Volchkova; Christopher F Basler; Peter Palese; Viktor E Volchkov; Megan L Shaw
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

7.  A single amino acid substitution in the V protein of Nipah virus alters its ability to block interferon signalling in cells from different species.

Authors:  Kathrin Hagmaier; Nicola Stock; Steve Goodbourn; Lin-Fa Wang; Richard Randall
Journal:  J Gen Virol       Date:  2006-12       Impact factor: 3.891

8.  Transmission of human infection with Nipah virus.

Authors:  Stephen P Luby; Emily S Gurley; M Jahangir Hossain
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

9.  Nipah virus infection: current scenario.

Authors:  D D Kulkarni; C Tosh; G Venkatesh; D Senthil Kumar
Journal:  Indian J Virol       Date:  2013-11-07

10.  Nonstructural Nipah virus C protein regulates both the early host proinflammatory response and viral virulence.

Authors:  Cyrille Mathieu; Vanessa Guillaume; Valentina A Volchkova; Christine Pohl; Frederique Jacquot; Ren Yih Looi; Kum Thong Wong; Catherine Legras-Lachuer; Viktor E Volchkov; Joel Lachuer; Branka Horvat
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.